The gut microbiota has recently been recognized as a major environmental factor in the pathophysiology of many human diseases. The anatomical and function connection existing between gut and liver provides the theoretical basis to assume the liver is a major target for gut microbes. In the last decades, numerous studies reported an altered composition of gut microbiota in patients with liver cirrhosis and a progressively marked dysbiosis with worsening of the liver disease. The risk of developing hepatocellular carcinoma, the deadliest complication of liver cirrhosis, is widely variable among cirrhotic patients, thus suggesting a complexity of genetic and environmental factors implicated in hepatocarcinogenesis. Gut microbiota is now emerging as a plausible candidate to explain this variability. In this manuscript we review the human and the experimental evidence supporting the potential implication of gut microbiota in the promotion, progression and complication of liver disease.

The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma / Sanduzzi Zamparelli, Marco; Rocco, Alba; Compare, Debora; Nardone, Gerardo. - In: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. - ISSN 2050-6406. - 5:7(2017), pp. 944-953. [10.1177/2050640617705576]

The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma

Sanduzzi Zamparelli, Marco
Writing – Original Draft Preparation
;
Rocco, Alba
Writing – Original Draft Preparation
;
Compare, Debora
Writing – Original Draft Preparation
;
Nardone, Gerardo
Writing – Review & Editing
2017

Abstract

The gut microbiota has recently been recognized as a major environmental factor in the pathophysiology of many human diseases. The anatomical and function connection existing between gut and liver provides the theoretical basis to assume the liver is a major target for gut microbes. In the last decades, numerous studies reported an altered composition of gut microbiota in patients with liver cirrhosis and a progressively marked dysbiosis with worsening of the liver disease. The risk of developing hepatocellular carcinoma, the deadliest complication of liver cirrhosis, is widely variable among cirrhotic patients, thus suggesting a complexity of genetic and environmental factors implicated in hepatocarcinogenesis. Gut microbiota is now emerging as a plausible candidate to explain this variability. In this manuscript we review the human and the experimental evidence supporting the potential implication of gut microbiota in the promotion, progression and complication of liver disease.
2017
The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma / Sanduzzi Zamparelli, Marco; Rocco, Alba; Compare, Debora; Nardone, Gerardo. - In: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. - ISSN 2050-6406. - 5:7(2017), pp. 944-953. [10.1177/2050640617705576]
File in questo prodotto:
File Dimensione Formato  
UEG2017.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 155.46 kB
Formato Adobe PDF
155.46 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/712945
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 37
social impact